These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7894602)

  • 1. Design of novel synthetic peptides including cyclic conformationally and topographically constrained analogs.
    Hruby VJ; Bonner GG
    Methods Mol Biol; 1994; 35():201-40. PubMed ID: 7894602
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromoacetylated synthetic peptides. Starting materials for cyclic peptides, peptomers, and peptide conjugates.
    Robey FA
    Methods Mol Biol; 1994; 35():73-90. PubMed ID: 7894610
    [No Abstract]   [Full Text] [Related]  

  • 3. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display.
    Meyer SC; Gaj T; Ghosh I
    Chem Biol Drug Des; 2006 Jul; 68(1):3-10. PubMed ID: 16923020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.
    Tam JP; Lu YA; Yang JL
    Biochem Biophys Res Commun; 2000 Jan; 267(3):783-90. PubMed ID: 10673369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of bioactive and structurally well-defined peptides from conformationally restricted libraries.
    Pastor MT; Mora P; Ferrer-Montiel A; Pérez-Payá E
    Biopolymers; 2004; 76(4):357-65. PubMed ID: 15386263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of alpha-helical peptides and mimetics.
    Garner J; Harding MM
    Org Biomol Chem; 2007 Nov; 5(22):3577-85. PubMed ID: 17971985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
    Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
    J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From IHF protein to design and synthesis of a sequence-specific DNA bending peptide.
    Liebler EK; Diederichsen U
    Org Lett; 2004 Aug; 6(17):2893-6. PubMed ID: 15330641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific chemical modification procedures.
    Pennington MW
    Methods Mol Biol; 1994; 35():171-85. PubMed ID: 7894599
    [No Abstract]   [Full Text] [Related]  

  • 10. The cyclotides: novel macrocyclic peptides as scaffolds in drug design.
    Craik DJ; Simonsen S; Daly NL
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):251-60. PubMed ID: 11926131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclization of peptides and depsipeptides.
    Davies JS
    J Pept Sci; 2003 Aug; 9(8):471-501. PubMed ID: 12952390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated solid-phase synthesis of cyclic peptides bearing a side-chain tail designed for subsequent chemical grafting.
    Delforge D; Art M; Gillon B; Dieu M; Delaive E; Raes M; Remacle J
    Anal Biochem; 1996 Nov; 242(2):180-6. PubMed ID: 8937560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase synthesis of peptides containing the CH2NH reduced bond surrogate.
    Pennington MW
    Methods Mol Biol; 1994; 35():241-7. PubMed ID: 7894603
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbohydrates in peptide and protein design.
    Jensen KJ; Brask J
    Biopolymers; 2005; 80(6):747-61. PubMed ID: 15929028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of cell-penetrating peptides for cargo delivery.
    Pooga M; Langel U
    Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of cyclic and linear peptide-agarose tools for baiting interacting protein partners of GPCRs.
    Granier S; Jean-Alphonse F; Déméné H; Guillon G; Pascal R; Mendre C
    Bioorg Med Chem Lett; 2006 Feb; 16(3):521-4. PubMed ID: 16289816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
    Pak VV; Koo M; Yun L; Kwon DY
    J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methylated cyclic pentaalanine peptides as template structures.
    Chatterjee J; Mierke D; Kessler H
    J Am Chem Soc; 2006 Nov; 128(47):15164-72. PubMed ID: 17117868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid cleavage/deprotection in Fmoc/tBu solid-phase peptide synthesis.
    Dick F
    Methods Mol Biol; 1994; 35():63-72. PubMed ID: 7894609
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and biologic activity of conformationally constrained analogs of L-363,301.
    Moore SB; Grant M; Rew Y; Bosa E; Fabbri M; Kumar U; Goodman M
    J Pept Res; 2005 Dec; 66(6):404-22. PubMed ID: 16316457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.